Navigation Links
Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis

of the onset of the disease. RA can interfere with a person's ability to work due to joint pain, fatigue and joint tenderness and damage. Several studies have shown that patients with RA have limited employment possibilities and reduced productivity at work.

    Study Highlights:

    -- PROWD is a multi-center, randomized, 56-week controlled trial that

       examined the effect of HUMIRA plus MTX versus placebo plus MTX on job

       loss due to all causes and imminent job loss in 148 early RA patients.

       Although the changes in job loss related to all causes -- not specific

       to disability alone -- did not reach significance between weeks 16 and

       56, results showed that significantly more patients on MTX alone

       reported job loss compared to patients taking HUMIRA plus MTX during

       the entire period of 56 weeks (40 percent vs. 19 percent).  The

       investigators concluded that HUMIRA plus MTX reduced RA-related job

       loss and reduced work time lost in patients with early RA more than MTX

       alone.


    -- DE032 is an economic companion study to PREMIER, a two-year,

       double-blind controlled study that compared the effectiveness of

       HUMIRA, MTX and the combination of the two drugs in treating early RA.

       The DE032 study compared HUMIRA plus MTX (n=219) to MTX alone (n=214)

       on patient-reported measures of work performance in both paid workers

       and homemakers.  Results showed that after two years, paid workers and

       homemakers taking MTX alone missed significantly more workdays than

       patients taking HUMIRA plus MTX (26 vs. 15 and 14 vs. 7, respectively).

       In addition, patients on HUMIRA plus MTX were 21 percent more likely to

       gain or retain employment compared to patients on MTX alone at the end

       of two years.


    -- DE033, an open label DMARD registry controlled study, examined the

       long-term impact on employment tenure and likel
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
2. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
3. Three New Drugs Mark New Era in Rheumatoid Arthritis Treatment
4. ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds for Solid Tumors Are to be Reported at ASCO
5. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
6. Isotechnika Announces Interim Three Month Data from Phase 2b Kidney Transplant Trial
7. Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
8. EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds
9. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
Post Your Comments:
(Date:8/29/2014)... -- According to the new research ... Reagent, Primer, Probe, Custom Oligos), End-User (Research, Pharmaceutical ... NGS, DNA, RNAi) - Global Forecast to 2019" ... is expected to reach $1,712.1 Million by 2019 ... CAGR of 9.8% from 2014 to 2019.. ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)... MENLO PARK, Calif. , Aug. 29, 2014 /PR ... ("DelMar" "the Company") today announced the filing of June ... changed its fiscal year end to June 30th in ... stock on a national securities exchange in the timeliest ... with the United States Securities Exchange Commission can be ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... and FARGO, N.D., Dec. 16, 2011  Crystal3 Labs, Inc., a ... FL, announced today that it has been acquired by ... Financial terms of the transaction were not disclosed. The ... Pharma Analytics. Founded in 2007, Global Pharma ...
... 2011 Ekahau Inc. the leading global provider ... and KARL STORZ GmbH & Co. KG, the endoscopy specialist, ... Clinic in Berlin has successfully deployed and is using the ... and Ekahau RTLS for automatic real-time management of ...
Cached Medicine Technology:Crystal3 Labs Acquired by Individual Investor, Vithalbhai Dhaduk, M.D. 2Hospital Operating Rooms are now Optimized in Real-time With a Joint Solution From Karl Storz and Ekahau 2Hospital Operating Rooms are now Optimized in Real-time With a Joint Solution From Karl Storz and Ekahau 3Hospital Operating Rooms are now Optimized in Real-time With a Joint Solution From Karl Storz and Ekahau 4
(Date:8/30/2014)... United Theological Seminary is pleased to announce the launch of ... Studies (MTS). , This degree, which can ... wish to pursue further academic study of religion (Ph.D.) or ... and community. Previously, students needed to be on campus to ... any location where there is an internet connection. , ...
(Date:8/30/2014)... Denver, Colorado (PRWEB) August 30, 2014 Daily ... Cure for Yeast Infection is a method created by Sarah ... means. , The author of this new program actually ... created for any sufferer to be able to access it, ... had an important determination in finding an effective cure for ...
(Date:8/30/2014)... NY (PRWEB) August 30, 2014 ... throughout the planet has been one of the ... order to create a positive impact around the ... and staffed with top trained executives and trainers ... of people worldwide. Vital statistics demonstrate that ...
(Date:8/30/2014)... York (PRWEB) August 30, 2014 Hundreds ... mimetic claims continue to move forward in U.S. courts, ... by AstraZeneca PLC on July 31, 2014, Byetta and ... in 409 product liability claims that allege the drugs ... indicate that many of these claims are pending in ...
(Date:8/30/2014)... 30, 2014 Hastings and Hastings, a ... located throughout Arizona is pleased to report having saved ... specific example among many cases where Hastings and Hastings ... to retain a greater portion of their settlement or ... providing a positive solution for Arizona car accident victims ...
Breaking Medicine News(10 mins):Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Natural Cure for Yeast Infection Review Exposes New Natural Treatment 2Health News:Cradle of Aviation Museum Opens Its Doors to Long Island Scientologists 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 2Health News:Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2
... /PRNewswire/ - VisualSonics Inc., a leader in real time, ... the Board of Directors has permanently appointed Anil Amlani, ... Mr. Amlani, previously the Chief Financial Officer, has served ... 2009. , "VisualSonics has aggressive growth plans to expand ...
... , PHOENIX, Nov. 3 A healthy 44-year-old woman will ... Keri Sweeten and a new blood test for breast cancer. ... American College of Obstetricians and Gynecologists, recently incorporated the Provista ... of breast cancer, into her patient care practice. Sweeten noted ...
... ... best , ... November 3, 2009 -- Following approval by their Boards of Trustees, South Dakota-based Sanford ... two organizations have merged to become one of the country,s largest integrated health care systems. ...
... ... programs. , ... (PRWEB) November 3, 2009 -- Greenbrier Academy is a private young women,s ... transformative therapeutics. The school embraces virtuous relationships, personal excellence, and emotional breakthroughs inspiring ...
... ... the world,s first portable meeting cost calculator and clock. With Bring TIM!, time management is ... , ... November 3, 2009 -- Bring TIM! LLC announces the launch of Bring TIM!®, its new ...
... tubs, whirlpools and spas are widely used for relaxation and ... past two decades, as recreational use of hot tubs has ... conducted by the Center for Injury Research and Policy of ... 1990-2007, the number of unintentional hot tub-related injuries increased by ...
Cached Medicine News:Health News:VisualSonics Appoints New President and CEO 2Health News:A Breast Cancer Test That Saves Lives 2Health News:A Breast Cancer Test That Saves Lives 3Health News:Sanford and MeritCare Create a New Health System 2Health News:Sanford and MeritCare Create a New Health System 3Health News:Sanford and MeritCare Create a New Health System 4Health News:Therapeutic Boarding School to Provide Services Nationally 2Health News:Need a New Time Management Tool for Long Business Meetings? Bring TIM! 2Health News:New national study finds increasing number of injuries from hot tubs 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: